Mallinckrodt Announces Appointments Following Questcor Acquisition

(RTTNews) - Mallinckrodt Plc (MNK) Friday announced that Gary Phillips, current Senior Vice President and Chief Strategy Officer, has been appointed to serve as Senior Vice President and President of the company's Autoimmune and Rare Disease business.

In addition, Ray Furey, formerly Senior Vice President and Chief Compliance Officer at Questcor Pharmaceuticals, has been appointed as Senior Vice President and the Chief Compliance Officer at Mallinckrodt. The appointments are effective immediately, the firm said. In his new role, Phillips will assume responsibility for the Acthar franchise and all of its sales, support and service activities. He will continue to serve as a member of Mallinckrodt's Executive Committee.

Furey will also join Mallinckrodt's Executive Committee and have a dotted line reporting relationship to the Mallinckrodt Board of Directors.

Both executives will report directly to Mark Trudeau, Chief Executive Officer of Mallinckrodt.